Owner Janssen Pharmaceutica N.V.

Inventors Jurzak, Mirek; Heylen, Godelieve Irma Christine Maria; Janssen, Cornelus Gerardus Maria

Agent Shelston IP

Pub. Number AU-B-2002328312

PCT Number PCT/EP02/07364

PCT Pub. Number WO2003/006988

Priority 01202689.4 13.07.01 EP

Filing date 2 July 2002

Wipo publication date 29 January 2003

Acceptance publication date 14 December 2006

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12Q 1/02 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving viable micro-organisms

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 33/15 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Medicinal preparations

G01N 33/60 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving radioactive labelled substances

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids